New Millennium Group »

Aurinia Pharmaceuticals shares owned by New Millennium Group

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by New Millennium Group from 13F filings

Historical chart of New Millennium Group investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by New Millennium Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by New Millennium Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.8k 708 11.05

More positions owned by New Millennium Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)
Apple (AAPL)
Amazon (AMZN)
Ge Aerospace Com New (GE)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Curtiss-Wright (CW)
Interactive Brokers Group In Com Cl A (IBKR)
Comfort Systems USA (FIX)
Ge Vernova (GEV)
Visa Com Cl A (V)

View all positions for New Millennium Group

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Vanguard Group
Geode Capital Management
Marshall Wace
Renaissance Technologies
Two Sigma Investments
Jacobs Levy Equity Management
Jane Street
Qube Research & Technologies
Henderson Group

View all funds holding Aurinia Pharmaceuticals